CA
VRTX icon

Cetera Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Cetera Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$5.82M Buy
13,912
+5,390
+63% +$2.28M 0.05% 407
2023
Q4 		$3.47M Buy
8,522
+1,568
+23% +$579K 0.05% 359
2023
Q3 		$2.42M Sell
6,954
-201
-3% -$70.3K 0.04% 404
2023
Q2 		$2.52M Buy
7,155
+212
+3% +$71.4K 0.04% 398
2023
Q1 		$2.19M Sell
6,943
-2,076
-23% -$623K 0.04% 416
2022
Q4 		$2.6M Buy
9,019
+1,010
+13% +$308K 0.05% 380
2022
Q3 		$2.32M Buy
8,009
+2,985
+59% +$859K 0.06% 327
2022
Q2 		$1.42M Sell
5,024
-287
-5% -$76.8K 0.03% 474
2022
Q1 		$1.39M Buy
5,311
+95
+2% +$22.5K 0.03% 505
2021
Q4 		$1.15M Sell
5,216
-12,737
-71% -$2.48M 0.02% 554
2021
Q3 		$3.26M Sell
17,953
-10,104
-36% -$1.97M 0.06% 296
2021
Q2 		$5.66M Buy
28,057
+23,172
+474% +$4.85M 0.13% 162
2021
Q1 		$1.05M Buy
4,885
+42
+0.9% +$9.22K 0.03% 464
2020
Q4 		$1.15M Buy
4,843
+642
+15% +$147K 0.04% 386
2020
Q3 		$1.14M Sell
4,201
-15
-0.4% -$4.14K 0.04% 351
2020
Q2 		$1.22M Buy
4,216
+1,678
+66% +$455K 0.05% 317
2020
Q1 		$604K Buy
2,538
+92
+4% +$21.1K 0.03% 422
2019
Q4 		$533K Buy
2,446
+18
+0.7% +$3.64K 0.02% 545
2019
Q3 		$412K Buy
2,428
+8
+0.3% +$1.42K 0.02% 603
2019
Q2 		$445K Sell
2,420
-91
-4% -$15.9K 0.02% 594
2019
Q1 		$462K Buy
2,511
+119
+5% +$22K 0.02% 516
2018
Q4 		$397K Sell
2,392
-1,430
-37% -$248K 0.02% 542
2018
Q3 		$739K Buy
3,822
+641
+20% +$114K 0.04% 438
2018
Q2 		$541K Buy
3,181
+4
+0.1% +$620 0.03% 489
2018
Q1 		$517K Buy
+3,177
New +$519K 0.03% 464

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Cetera Advisors's VRTX Position: Q1 2024 in Review

Cetera Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 63% in Q1 2024, buying an estimated $2.28M and bringing the position to 13,912 shares worth $5.82M. The position accounts for 0.05% of the portfolio, ranked #407.

Cetera Advisors first reported a position in VRTX in Q1 2018 and has held it in 25 quarters since. 1,493 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

  • Cetera Advisors held 13,912 shares of Vertex Pharmaceuticals worth $5.82M as of Q1 2024.
  • Cetera Advisors bought 5,390 Vertex Pharmaceuticals shares in Q1 2024, an estimated $2.28M.
  • Vertex Pharmaceuticals made up 0.05% of Cetera Advisors's portfolio in Q1 2024, its #407 holding.
  • Cetera Advisors first reported a position in Vertex Pharmaceuticals in Q1 2018 and has held it in 25 quarters since.
  • 1,493 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.